Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins.

Buzzetti, Raffaella; Fadini, Gian Paolo; Nicolucci, Antonio; Larosa, Monica; Rossi, Maria Chiara; Cucinotta, Domenico

Buzzetti, Raffaella; Fadini, Gian Paolo; Nicolucci, Antonio; Larosa, Monica; Rossi, Maria Chiara; Cucinotta, Domenico.

Afiliación

Buzzetti R; Department of Experimental Medicine, Sapienza University of Rome, Italy.
Fadini GP; Department of Medicine, University of Padova, Padua, Italy.
Nicolucci A; CORESEARCH - Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy. Electronic address: nicolucci@coresearch.it.
Larosa M; Medical Affairs, Sanofi Milan, Italy.
Rossi MC; CORESEARCH - Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy.
Cucinotta D; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Nutr Metab Cardiovasc Dis ; 32(9): 2255-2263, 2022 09.

Article en En | MEDLINE | ID: mdl-35961826

Asunto(s)

Diabetes Mellitus Tipo 2; Hipoglucemia; Glucemia; Hemoglobina Glucada; Humanos; Hipoglucemiantes; Insulina Glargina; Insulina de Acción Prolongada; Estudios Retrospectivos

Palabras clave

Basal insulin; Degludec 100; Effectiveness; Glargine 300; Safety; Switch; Type 2 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Hipoglucemia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nutr Metab Cardiovasc Dis Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / CIENCIAS DA NUTRICAO / METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google